v3.26.1
Condensed Consolidated Statements of Changes in Stockholders’ Equity (Unaudited) - USD ($)
Total
Preferred Stock
Common Stock
Class A Common Stock
Common Stock
Class C Common Stock
Additional Paid-in Capital
Additional Paid-in Capital
Class C Common Stock
 [1]
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2024   0 2,638,367 [1] 3,213,678      
Beginning balance at Dec. 31, 2024 $ 26,850,206 $ 0 $ 264 [1] $ 321 $ 146,750,049 [1]   $ (119,900,428)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock from Employee Stock Purchase Plan (in shares) [1]     266        
Issuance of shares for fully vested restricted stock units (in shares) [1]     25,301        
Issuance of shares for fully vested restricted stock units 0   $ 2 [1]   (2) [1]    
Share-based compensation 3,622,845       3,622,845 [1]    
Net loss (4,447,345)           (4,447,345)
Ending balance (in shares) at Mar. 31, 2025   0 2,663,934 [1] 3,213,678      
Ending balance at Mar. 31, 2025 26,025,706 $ 0 $ 266 [1] $ 321 150,372,892 [1]   (124,347,773)
Beginning balance (in shares) at Dec. 31, 2024   0 2,638,367 [1] 3,213,678      
Beginning balance at Dec. 31, 2024 26,850,206 $ 0 $ 264 [1] $ 321 146,750,049 [1]   (119,900,428)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss (12,813,325)            
Ending balance (in shares) at Jun. 30, 2025   0 2,845,069 [1] 3,213,678      
Ending balance at Jun. 30, 2025 22,451,393 $ 0 $ 284 [1] $ 321 155,164,541 [1]   (132,713,753)
Beginning balance (in shares) at Dec. 31, 2024   0 2,638,367 [1] 3,213,678      
Beginning balance at Dec. 31, 2024 26,850,206 $ 0 $ 264 [1] $ 321 146,750,049 [1]   (119,900,428)
Ending balance (in shares) at Dec. 31, 2025   0 3,099,509 [1] 3,213,678      
Ending balance at Dec. 31, 2025 13,436,906 $ 0 $ 310 [1] $ 321 169,948,371 [1]   (156,512,096)
Beginning balance (in shares) at Mar. 31, 2025   0 2,663,934 [1] 3,213,678      
Beginning balance at Mar. 31, 2025 26,025,706 $ 0 $ 266 [1] $ 321 150,372,892 [1]   (124,347,773)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock for asset acquisition (in shares) [1]     133,333        
Issuance of common stock for asset acquisition 4,500,000   $ 13 [1]   4,499,987 [1]    
Issuance of common stock for at-the-market offering, net (in shares) [1]     10,998        
Issuance of common stock for at-the-market offering, net 361,528   $ 1 [1]   361,527 [1]    
Issuance of shares for fully vested restricted stock units (in shares) [1]     36,804        
Issuance of shares for fully vested restricted stock units [1]     $ 4   (4)    
Share-based compensation (69,861)       (69,861) [1]    
Net loss (8,365,980)           (8,365,980)
Ending balance (in shares) at Jun. 30, 2025   0 2,845,069 [1] 3,213,678      
Ending balance at Jun. 30, 2025 22,451,393 $ 0 $ 284 [1] $ 321 155,164,541 [1]   (132,713,753)
Beginning balance (in shares) at Dec. 31, 2025   0 3,099,509 [1] 3,213,678      
Beginning balance at Dec. 31, 2025 13,436,906 $ 0 $ 310 [1] $ 321 169,948,371 [1]   (156,512,096)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of shares for fully vested restricted stock units (in shares) [1]     1,339        
Cancellation of Class C common stock (in shares)       (1,000,000)      
Cancellation of Class C Common Stock 0     $ (100) 100 [1]    
Conversion of Class C common stock to Class A common stock (in shares)     147,578 [1] (2,213,678)      
Conversion of Class C Common Stock to Class A Common Stock 0   $ 15 [1] $ (221)   $ 206  
Closing costs from private investment in public equity transaction [2] (22,091)       (22,091) [1]    
Share-based compensation 1,365,556       1,365,556 [1]    
Net loss (6,454,937)           (6,454,937)
Ending balance (in shares) at Mar. 31, 2026   0 3,248,426 [1] 0      
Ending balance at Mar. 31, 2026 8,325,434 $ 0 $ 325 [1] $ 0 171,292,142 [1]   (162,967,033)
Beginning balance (in shares) at Dec. 31, 2025   0 3,099,509 [1] 3,213,678      
Beginning balance at Dec. 31, 2025 13,436,906 $ 0 $ 310 [1] $ 321 169,948,371 [1]   (156,512,096)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss (12,076,028)            
Ending balance (in shares) at Jun. 30, 2026   0 3,353,852 [1] 0      
Ending balance at Jun. 30, 2026 4,186,691 $ 0 $ 336 [1] $ 0 172,774,479 [1]   (168,588,124)
Beginning balance (in shares) at Mar. 31, 2026   0 3,248,426 [1] 0      
Beginning balance at Mar. 31, 2026 8,325,434 $ 0 $ 325 [1] $ 0 171,292,142 [1]   (162,967,033)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock for at-the-market offering, net (in shares) [1]     29,322        
Issuance of common stock for at-the-market offering, net 248,733   $ 3 [1]   248,730 [1]    
Issuance of shares for fully vested restricted stock units (in shares) [1]     76,104        
Issuance of shares for fully vested restricted stock units 0   $ 8 [1]   (8) [1]    
Share-based compensation 1,233,615       1,233,615 [1]    
Net loss (5,621,091)           (5,621,091)
Ending balance (in shares) at Jun. 30, 2026   0 3,353,852 [1] 0      
Ending balance at Jun. 30, 2026 $ 4,186,691 $ 0 $ 336 [1] $ 0 $ 172,774,479 [1]   $ (168,588,124)
[1] Results have been adjusted to reflect the reverse stock split of the Class A Common Stock at a ratio of 1-for-15 that became effective July 13, 2026. See Note 1 — Organization and Business Operations for further details.
[2] Pre-funded warrants, issued in December 2025, can be exercised for nominal consideration (an exercise price per share equal to $0.0001 per share), and 334,545 remain unexercised as of June 30, 2026.